Search Results

You are looking at 11 - 20 of 105 items for :

  • nonalcoholic fatty liver disease x
Clear All
Leanne Hodson Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Oxford University Hospital Trusts, Oxford, UK

Search for other papers by Leanne Hodson in
Google Scholar
PubMed
Close
and
Fredrik Karpe Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Oxford University Hospital Trusts, Oxford, UK

Search for other papers by Fredrik Karpe in
Google Scholar
PubMed
Close

and fatty acid removal (via oxidation or export as triacylglycerol (TAG)) from the liver. Pathological accumulation of intra-hepatocellular TAG (IHTAG) is denoted as nonalcoholic liver disease (NAFLD), which encompasses a spectrum of conditions from

Open access
Stephen J Winters Division of Endocrinology, Metabolism and Diabetes, University of Louisville, Louisville, Kentucky, USA

Search for other papers by Stephen J Winters in
Google Scholar
PubMed
Close
,
Charles R Scoggins Division of Surgical Oncology, University of Louisville, Louisville, Kentucky, USA

Search for other papers by Charles R Scoggins in
Google Scholar
PubMed
Close
,
Duke Appiah Department of Public Health, Texas Tech University Health Sciences Center, Lubbock, Texas, USA

Search for other papers by Duke Appiah in
Google Scholar
PubMed
Close
, and
Dushan T Ghooray Division of Endocrinology, Metabolism and Diabetes, University of Louisville, Louisville, Kentucky, USA

Search for other papers by Dushan T Ghooray in
Google Scholar
PubMed
Close

. ( https://doi.org/10.1042/bj1610431 ) 29 Luo J Chen Q Shen T Wang X Fang W Wu X Yuan Z Chen G Ling W Chen Y Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults . Nutrition and

Open access
Tatsuya Kondo Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Chuo-Ward, Kumamoto, Japan

Search for other papers by Tatsuya Kondo in
Google Scholar
PubMed
Close
,
Nobukazu Miyakawa Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Nobukazu Miyakawa in
Google Scholar
PubMed
Close
,
Sayaka Kitano Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Chuo-Ward, Kumamoto, Japan

Search for other papers by Sayaka Kitano in
Google Scholar
PubMed
Close
,
Takuro Watanabe Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Takuro Watanabe in
Google Scholar
PubMed
Close
,
Rieko Goto Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Rieko Goto in
Google Scholar
PubMed
Close
,
Mary Ann Suico Department of Molecular Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Mary Ann Suico in
Google Scholar
PubMed
Close
,
Miki Sato Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Miki Sato in
Google Scholar
PubMed
Close
,
Yuki Takaki Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Yuki Takaki in
Google Scholar
PubMed
Close
,
Masaji Sakaguchi Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Masaji Sakaguchi in
Google Scholar
PubMed
Close
,
Motoyuki Igata Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Chuo-Ward, Kumamoto, Japan

Search for other papers by Motoyuki Igata in
Google Scholar
PubMed
Close
,
Junji Kawashima Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Junji Kawashima in
Google Scholar
PubMed
Close
,
Hiroyuki Motoshima Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Hiroyuki Motoshima in
Google Scholar
PubMed
Close
,
Takeshi Matsumura Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Takeshi Matsumura in
Google Scholar
PubMed
Close
,
Hirofumi Kai Department of Molecular Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Hirofumi Kai in
Google Scholar
PubMed
Close
, and
Eiichi Araki Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Eiichi Araki in
Google Scholar
PubMed
Close

diabetes-associated nonalcoholic fatty liver disease . Journal of Clinical and Experimental Hepatology 2019 9 607 – 618 . ( https://doi.org/10.1016/j.jceh.2018.10.004 ) 3 Kadowaki S Tamura Y Someya Y Takeno K Kaga H Sugimoto D Kakehi

Open access
Xiaonan Guo Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Xiaonan Guo in
Google Scholar
PubMed
Close
,
Wenjing Hu Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Wenjing Hu in
Google Scholar
PubMed
Close
,
Xiaorui Lyu Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Xiaorui Lyu in
Google Scholar
PubMed
Close
,
Hanyuan Xu Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Hanyuan Xu in
Google Scholar
PubMed
Close
,
Huijuan Zhu Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Huijuan Zhu in
Google Scholar
PubMed
Close
,
Hui Pan Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Hui Pan in
Google Scholar
PubMed
Close
,
Linjie Wang Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Linjie Wang in
Google Scholar
PubMed
Close
,
Hongbo Yang Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Hongbo Yang in
Google Scholar
PubMed
Close
, and
Fengying Gong Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for other papers by Fengying Gong in
Google Scholar
PubMed
Close

secondary deficiency of IGF-1 ( 1 ). Several studies have shown that congenital GHD is associated with an increased risk of metabolic syndromes, such as nonalcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and hyperlipidemia ( 4

Open access
Till Ittermann Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Till Ittermann in
Google Scholar
PubMed
Close
,
Rehman Mehmood Khattak Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
Department of Zoology, Islamia College Peshawar (CU), Peshawar, Pakistan

Search for other papers by Rehman Mehmood Khattak in
Google Scholar
PubMed
Close
,
Marcello R P Markus Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Marcello R P Markus in
Google Scholar
PubMed
Close
,
Jens-Peter Kühn Institute of Radiology, University Hospital, Carl-Gustav-Carus University, Dresden, Germany

Search for other papers by Jens-Peter Kühn in
Google Scholar
PubMed
Close
,
Marie-Luise Kromrey Department of Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Marie-Luise Kromrey in
Google Scholar
PubMed
Close
,
Giovanni Targher Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy

Search for other papers by Giovanni Targher in
Google Scholar
PubMed
Close
,
Antje Steveling Department of Internal Medicine A, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Antje Steveling in
Google Scholar
PubMed
Close
,
Matthias Nauck Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, Greifswald, Germany

Search for other papers by Matthias Nauck in
Google Scholar
PubMed
Close
, and
Henry Völzke Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Henry Völzke in
Google Scholar
PubMed
Close

Introduction Non-alcoholic fatty liver disease (NAFLD) is a common finding in individuals with obesity or type 2 diabetes mellitus and its prevalence is steeply increasing worldwide ( 1 ). Recent meta-analyses of observational studies revealed

Open access
Frederique Van de Velde Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Frederique Van de Velde in
Google Scholar
PubMed
Close
,
Marlies Bekaert Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Marlies Bekaert in
Google Scholar
PubMed
Close
,
Anja Geerts Department of Hepatology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Anja Geerts in
Google Scholar
PubMed
Close
,
Anne Hoorens Department of Pathology, Ghent University Hospital

Search for other papers by Anne Hoorens in
Google Scholar
PubMed
Close
,
Arsène-Hélène Batens Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Arsène-Hélène Batens in
Google Scholar
PubMed
Close
,
Samyah Shadid Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Samyah Shadid in
Google Scholar
PubMed
Close
,
Margriet Ouwens Department of Endocrinology, Ghent University Hospital, Ghent, Belgium
Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center at the Heinrich-Heine-University Duesseldorf, Leibniz Center for Diabetes Research, Duesseldorf, Germany
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany

Search for other papers by Margriet Ouwens in
Google Scholar
PubMed
Close
,
Yves Van Nieuwenhove Department of Gastrointestinal Surgery, Ghent University Hospital, Ghent, Belgium

Search for other papers by Yves Van Nieuwenhove in
Google Scholar
PubMed
Close
, and
Bruno Lapauw Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Bruno Lapauw in
Google Scholar
PubMed
Close

Introduction An important complication of obesity is the development of nonalcoholic fatty liver disease (NAFLD), which covers a broad histological spectrum from simple steatosis to nonalcoholic steatohepatitis (NASH), and can progress to

Open access
Helle Keinicke Insulin and Device Trial Operations, Novo Nordisk A/S, Søborg, Denmark

Search for other papers by Helle Keinicke in
Google Scholar
PubMed
Close
,
Gao Sun Pharmacology and Histopathology, Novo Nordisk A/S, China

Search for other papers by Gao Sun in
Google Scholar
PubMed
Close
,
Caroline M Junker Mentzel Department of Experimental Animal Models, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark

Search for other papers by Caroline M Junker Mentzel in
Google Scholar
PubMed
Close
,
Merete Fredholm Department of Veterinary Clinical and Animal Science, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg C, Denmark

Search for other papers by Merete Fredholm in
Google Scholar
PubMed
Close
,
Linu Mary John Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Linu Mary John in
Google Scholar
PubMed
Close
,
Birgitte Andersen Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Birgitte Andersen in
Google Scholar
PubMed
Close
,
Kirsten Raun Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Kirsten Raun in
Google Scholar
PubMed
Close
, and
Marina Kjaergaard Global Obesity and Liver Disease Research, Novo Nordisk A/S, Måløv, Denmark

Search for other papers by Marina Kjaergaard in
Google Scholar
PubMed
Close

Introduction Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in the Western world ( 1 , 2 ) with a global prevalence of 25% ( 3 ). It is defined as steatosis (fat accumulation) in at least 5% of hepatocytes ( 3

Open access
Rachel D C A Diniz
Search for other papers by Rachel D C A Diniz in
Google Scholar
PubMed
Close
,
Renata M Souza
Search for other papers by Renata M Souza in
Google Scholar
PubMed
Close
,
Roberto Salvatori Division of Endocrinology, Division of Endocrinology, Division of Hepatology, Division of Radiology, Diabetes and Metabolism, Federal University of Sergipe, Aracaju, Brazil

Search for other papers by Roberto Salvatori in
Google Scholar
PubMed
Close
,
Alex Franca Division of Endocrinology, Division of Endocrinology, Division of Hepatology, Division of Radiology, Diabetes and Metabolism, Federal University of Sergipe, Aracaju, Brazil

Search for other papers by Alex Franca in
Google Scholar
PubMed
Close
,
Elenilde Gomes-Santos
Search for other papers by Elenilde Gomes-Santos in
Google Scholar
PubMed
Close
,
Thiago O Ferrão Division of Endocrinology, Division of Endocrinology, Division of Hepatology, Division of Radiology, Diabetes and Metabolism, Federal University of Sergipe, Aracaju, Brazil

Search for other papers by Thiago O Ferrão in
Google Scholar
PubMed
Close
,
Carla R P Oliveira
Search for other papers by Carla R P Oliveira in
Google Scholar
PubMed
Close
,
João A M Santana
Search for other papers by João A M Santana in
Google Scholar
PubMed
Close
,
Francisco A Pereira
Search for other papers by Francisco A Pereira in
Google Scholar
PubMed
Close
,
Rita A A Barbosa
Search for other papers by Rita A A Barbosa in
Google Scholar
PubMed
Close
,
Anita H O Souza
Search for other papers by Anita H O Souza in
Google Scholar
PubMed
Close
,
Rossana M C Pereira
Search for other papers by Rossana M C Pereira in
Google Scholar
PubMed
Close
,
Alécia A Oliveira-Santos
Search for other papers by Alécia A Oliveira-Santos in
Google Scholar
PubMed
Close
,
Allysson M P Silva
Search for other papers by Allysson M P Silva in
Google Scholar
PubMed
Close
,
Francisco J Santana-Júnior
Search for other papers by Francisco J Santana-Júnior in
Google Scholar
PubMed
Close
,
Eugênia H O Valença
Search for other papers by Eugênia H O Valença in
Google Scholar
PubMed
Close
,
Viviane C Campos
Search for other papers by Viviane C Campos in
Google Scholar
PubMed
Close
, and
Manuel H Aguiar-Oliveira
Search for other papers by Manuel H Aguiar-Oliveira in
Google Scholar
PubMed
Close

Introduction Nonalcoholic fatty liver disease (NAFLD) is a manifestation of the metabolic syndrome and is associated with very common conditions such as obesity, type 2 diabetes, hypertension, dyslipidemia, and atherosclerosis (1) . NAFLD includes

Open access
Xu Chen Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China
Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China

Search for other papers by Xu Chen in
Google Scholar
PubMed
Close
,
Yi Tang Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China

Search for other papers by Yi Tang in
Google Scholar
PubMed
Close
,
Shen Chen Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China

Search for other papers by Shen Chen in
Google Scholar
PubMed
Close
,
Wenhua Ling Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China

Search for other papers by Wenhua Ling in
Google Scholar
PubMed
Close
, and
Qing Wang Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China

Search for other papers by Qing Wang in
Google Scholar
PubMed
Close

Introduction Non-alcoholic fatty liver disease (NAFLD), which is considered to be the hepatic manifestation of the metabolic syndrome is defined as the abnormal hepatic triglyceride (TG) accumulation without excessive alcohol use. NAFLD

Open access
Panagiotis Anagnostis Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

Search for other papers by Panagiotis Anagnostis in
Google Scholar
PubMed
Close
,
Irene Lambrinoudaki 2nd Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Medical School, Athens, Greece

Search for other papers by Irene Lambrinoudaki in
Google Scholar
PubMed
Close
,
John C Stevenson National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield Hospitals, Guy’s and St Thomas’ NHS Foundation Trust, London, UK

Search for other papers by John C Stevenson in
Google Scholar
PubMed
Close
, and
Dimitrios G Goulis Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

Search for other papers by Dimitrios G Goulis in
Google Scholar
PubMed
Close

, atherogenic dyslipidemia, glucose intolerance, arterial hypertension (AH) and non-alcoholic fatty liver disease (NAFLD), compared with premenopausal status ( 5 ). In detail, transition to menopause leads to body fat redistribution toward the male pattern of

Open access